FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3097432564> ?p ?o ?g. }

• W3097432564 endingPage "253" @default.
• W3097432564 startingPage "241" @default.
• W3097432564 abstract "Rheumatoid arthritis (RA) is an autoimmune disorder that affects joints and is characterized by synovial hyperplasia and bone erosion associated with neovascularization and infiltration of proinflammatory cells. The introduction of biological disease-modifying anti-rheumatic drugs has dramatically changed the treatment of RA over the last 20 years. However, fewer than 50% of RA patients enter remission, and 10-15% are treatment refractory. There is currently no cure for RA. Fractalkine (FKN, also known as CX3CL1) is a cell membrane-bound chemokine that can be induced on activated vascular endothelial cells. FKN has dual functions as a cell adhesion molecule and a chemoattractant. FKN binds specifically to the chemokine receptor CX3CR1, which is selectively expressed on subsets of immune cells such as patrolling monocytes and killer lymphocytes. The FKN-CX3CR1 axis is thought to play important roles in the initiation of the inflammatory cascade and can contribute to exacerbation of tissue injury in inflammatory diseases. Accordingly, studies in animal models have shown that inhibition of the FKN-CX3CR1 axis not only improves rheumatic diseases but also reduces associated complications, such as pulmonary fibrosis and cardiovascular disease. Recently, a humanized anti-FKN monoclonal antibody, E6011, showed promising efficacy with a dose-dependent clinical response and favorable safety profile in a Phase 2 clinical trial in patients with RA (NCT02960438). Taken together, the preclinical and clinical results suggest that E6011 may represent a new therapeutic approach for rheumatic diseases by suppressing a major contributor to inflammation and mitigating concomitant cardiovascular and fibrotic diseases. In this review, we describe the role of the FKN-CX3CR1 axis in rheumatic diseases and the therapeutic potential of anti-FKN monoclonal antibodies to fulfill unmet clinical needs." @default.
• W3097432564 created "2020-11-09" @default.
• W3097432564 creator A5014507927 @default.
• W3097432564 creator A5015953107 @default.
• W3097432564 creator A5027763231 @default.
• W3097432564 creator A5044519948 @default.
• W3097432564 creator A5051805339 @default.
• W3097432564 creator A5061087608 @default.
• W3097432564 date "2020-11-01" @default.
• W3097432564 modified "2023-10-13" @default.
• W3097432564 title "<p>Emerging Role of Fractalkine in the Treatment of Rheumatic Diseases</p>" @default.
• W3097432564 cites W110542923 @default.
• W3097432564 cites W1493971026 @default.
• W3097432564 cites W1500501026 @default.
• W3097432564 cites W1519962349 @default.
• W3097432564 cites W1560566673 @default.
• W3097432564 cites W1566903555 @default.
• W3097432564 cites W1586392520 @default.
• W3097432564 cites W1736954244 @default.
• W3097432564 cites W1871544114 @default.
• W3097432564 cites W1912357555 @default.
• W3097432564 cites W1913934781 @default.
• W3097432564 cites W1967974124 @default.
• W3097432564 cites W1969945556 @default.
• W3097432564 cites W1983933581 @default.
• W3097432564 cites W1984115097 @default.
• W3097432564 cites W1984378291 @default.
• W3097432564 cites W1985502949 @default.
• W3097432564 cites W1988228894 @default.
• W3097432564 cites W1993160453 @default.
• W3097432564 cites W1998533064 @default.
• W3097432564 cites W1999908428 @default.
• W3097432564 cites W2006166044 @default.
• W3097432564 cites W2008669330 @default.
• W3097432564 cites W2009937178 @default.
• W3097432564 cites W2011363498 @default.
• W3097432564 cites W2022585532 @default.
• W3097432564 cites W2025441604 @default.
• W3097432564 cites W2025732663 @default.
• W3097432564 cites W2026578487 @default.
• W3097432564 cites W2045917274 @default.
• W3097432564 cites W2053315646 @default.
• W3097432564 cites W2062623868 @default.
• W3097432564 cites W2069341622 @default.
• W3097432564 cites W2071306907 @default.
• W3097432564 cites W2074838002 @default.
• W3097432564 cites W2080844075 @default.
• W3097432564 cites W2086438959 @default.
• W3097432564 cites W2088098711 @default.
• W3097432564 cites W2089573422 @default.
• W3097432564 cites W2101939713 @default.
• W3097432564 cites W2102862146 @default.
• W3097432564 cites W2106171259 @default.
• W3097432564 cites W2108670276 @default.
• W3097432564 cites W2110376368 @default.
• W3097432564 cites W2110797670 @default.
• W3097432564 cites W2110826367 @default.
• W3097432564 cites W2116042273 @default.
• W3097432564 cites W2120393706 @default.
• W3097432564 cites W2124145166 @default.
• W3097432564 cites W2126972955 @default.
• W3097432564 cites W2127316787 @default.
• W3097432564 cites W2130372951 @default.
• W3097432564 cites W2132276397 @default.
• W3097432564 cites W2134132890 @default.
• W3097432564 cites W2142738135 @default.
• W3097432564 cites W2147303583 @default.
• W3097432564 cites W2148180540 @default.
• W3097432564 cites W2150463269 @default.
• W3097432564 cites W2155444336 @default.
• W3097432564 cites W2155712856 @default.
• W3097432564 cites W2156861923 @default.
• W3097432564 cites W2158550197 @default.
• W3097432564 cites W2159520783 @default.
• W3097432564 cites W2166328404 @default.
• W3097432564 cites W2169344483 @default.
• W3097432564 cites W2206432491 @default.
• W3097432564 cites W2283215190 @default.
• W3097432564 cites W2284570892 @default.
• W3097432564 cites W2431719516 @default.
• W3097432564 cites W2470473356 @default.
• W3097432564 cites W2486559230 @default.
• W3097432564 cites W2517825632 @default.
• W3097432564 cites W2553726688 @default.
• W3097432564 cites W2563825740 @default.
• W3097432564 cites W2573868425 @default.
• W3097432564 cites W2585122285 @default.
• W3097432564 cites W2590072483 @default.
• W3097432564 cites W2603807054 @default.
• W3097432564 cites W2605393985 @default.
• W3097432564 cites W2626574050 @default.
• W3097432564 cites W2730857027 @default.
• W3097432564 cites W2740276775 @default.
• W3097432564 cites W2762986374 @default.
• W3097432564 cites W2768709220 @default.
• W3097432564 cites W2778531418 @default.
• W3097432564 cites W2789956380 @default.
• W3097432564 cites W2790463973 @default.

• next